MoneyWorks4Me

An increase of about 100.54% to Rs. 1270.29 millions in the total revenue was observed for the quarter ended December 2024. The total revenue was pegged at Rs. 633.42 millions during the similar quarter previous year.Profit for the quarter ended December 2024 rises by 99.21% to Rs. 127.91  millions from Rs. 64.21 millions.Operating Profit saw a handsome growth to 184.24 millions from 111.49 millions in the quarter ended December 2024.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202412 202312 % Var 202412 202312 % Var 202403 202303 % Var
Sales 1270.29 633.42 100.54 3153.52 1850.93 70.37 2583.60 2246.44 15.01
Other Income 38.25 43.49 -12.05 93.22 102.30 -8.88 131.01 146.10 -10.33
PBIDT 184.24 111.49 65.25 463.21 292.80 58.20 409.55 342.22 19.67
Interest 2.12 10.82 -80.41 7.60 32.80 -76.83 44.49 31.30 42.14
PBDT 182.12 100.43 81.34 455.59 259.76 75.39 364.82 311.05 17.29
Depreciation 13.08 14.46 -9.54 39.08 34.25 14.10 47.22 45.39 4.03
PBT 169.04 85.97 96.63 416.51 225.51 84.70 317.60 265.66 19.55
TAX 41.13 21.76 89.02 102.81 56.76 81.13 81.36 64.95 25.27
Deferred Tax 0.85 0.98 -13.27 3.29 5.11 -35.62 5.54 -1.53 -462.09
PAT 127.91 64.21 99.21 313.70 168.75 85.90 236.24 200.71 17.70
Equity 940.00 940.00 0.00 940.00 940.00 0.00 940.00 940.00 0.00
PBIDTM(%) 14.50 17.60 -17.60 14.69 15.82 -7.15 15.85 15.23 4.06
Peers
Company Name CMP
Sun Pharma. Inds. 1835.50
Dr. Reddys Labs. 1171.10
Cipla 1371.45
Lupin 2144.70
Zydus Lifesciences 1153.00
View more..